Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 07, 2019

SELL
$94.4 - $126.76 $145,281 - $195,083
-1,539 Closed
0 $0
Q3 2018

Nov 02, 2018

SELL
$108.41 - $127.64 $512,454 - $603,354
-4,727 Reduced 75.44%
1,539 $202,000
Q2 2018

Aug 03, 2018

BUY
$102.12 - $114.04 $30,636 - $34,212
300 Added 5.03%
6,266 $698,000
Q1 2018

Apr 26, 2018

BUY
$104.31 - $124.46 $37,968 - $45,303
364 Added 6.5%
5,966 $651,000
Q4 2017

Jan 30, 2018

SELL
$105.55 - $120.83 $4,116 - $4,712
-39 Reduced 0.69%
5,602 $676,000
Q3 2017

Oct 30, 2017

BUY
$106.92 - $117.79 $603,135 - $664,453
5,641
5,641 $661,000

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $22.7B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Fine Mark National Bank & Trust Portfolio

Follow Fine Mark National Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fine Mark National Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Fine Mark National Bank & Trust with notifications on news.